Intensity Therapeutics Long Term Debt

Intensity Therapeutics (INTS) currently reports a long-term debt of $62K as of June 2026. That compares with $190K in the prior-year period — down 67.4% year over year. Use the charts on this page to explore Intensity Therapeutics's long-term debt history and peer comparisons.

Intensity Therapeutics's long-term debt decreased from $190K to $62K — a 67.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Intensity Therapeutics reported $62K in long-term debt as of June 2026. That compares with $190K in the prior-year period — down 67.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $62K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Intensity Therapeutics, and consider following INTS for alerts when major investors trade the stock.